An in-depth look to SCHOTT PHARMA INH O.N. operating, investing, and financing activities

1SXP free cash flow for Q4 24 is 11.42 M EUR. For 2024, 1SXP free cash flow was 80.25 M EUR and operating cash flow was 225.33 M EUR.